These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9818284)

  • 1. Association between [18F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation.
    Crippa F; Seregni E; Agresti R; Chiesa C; Pascali C; Bogni A; Decise D; De Sanctis V; Greco M; Daidone MG; Bombardieri E
    Eur J Nucl Med; 1998 Oct; 25(10):1429-34. PubMed ID: 9818284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.
    García Vicente AM; Soriano Castrejón A; Relea Calatayud F; Muñoz Madero V; Molina Garrido MJ; León Martín AA; Cordero García JM; Pilkington Woll JP; Chacón López-Muñiz I; Palomar Muñoz A
    Rev Esp Med Nucl Imagen Mol; 2012; 31(6):308-14. PubMed ID: 23084013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
    Groheux D; Giacchetti S; Moretti JL; Porcher R; Espié M; Lehmann-Che J; de Roquancourt A; Hamy AS; Cuvier C; Vercellino L; Hindié E
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):426-35. PubMed ID: 21057787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
    Buck A; Schirrmeister H; Kühn T; Shen C; Kalker T; Kotzerke J; Dankerl A; Glatting G; Reske S; Mattfeldt T
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1317-23. PubMed ID: 12271413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardized uptake values for breast carcinomas assessed by fluorodeoxyglucose-positron emission tomography correlate with prognostic factors.
    Ikenaga N; Otomo N; Toyofuku A; Ueda Y; Toyoda K; Hayashi T; Nishikawa K; Tanaka M
    Am Surg; 2007 Nov; 73(11):1151-7. PubMed ID: 18092653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy.
    Koolen BB; Vrancken Peeters MJ; Wesseling J; Lips EH; Vogel WV; Aukema TS; van Werkhoven E; Gilhuijs KG; Rodenhuis S; Rutgers EJ; Valdés Olmos RA
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1830-8. PubMed ID: 22895862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
    Gil-Rendo A; Martínez-Regueira F; Zornoza G; García-Velloso MJ; Beorlegui C; Rodriguez-Spiteri N
    Br J Surg; 2009 Feb; 96(2):166-70. PubMed ID: 19160365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of
    Jena A; Taneja S; Singh A; Negi P; Sarin R; Das PK; Singhal M
    AJR Am J Roentgenol; 2017 Sep; 209(3):662-670. PubMed ID: 28678576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between primary tumour
    Gedik GK; Yilmaz F; Sari O
    Rev Esp Med Nucl Imagen Mol; 2017; 36(3):152-157. PubMed ID: 27856207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
    Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
    Ahn SG; Lee JH; Lee HW; Jeon TJ; Ryu YH; Kim KM; Sohn J; Yun M; Lee SA; Jeong J; Kim SI
    PLoS One; 2017; 12(4):e0175048. PubMed ID: 28419166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
    Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
    J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.
    Hyun SH; Ahn HK; Lee JH; Choi JY; Kim BT; Park YH; Im YH; Lee JE; Nam SJ; Lee KH
    PLoS One; 2016; 11(10):e0165814. PubMed ID: 27798667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study.
    Smyczek-Gargya B; Fersis N; Dittmann H; Vogel U; Reischl G; Machulla HJ; Wallwiener D; Bares R; Dohmen BM
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):720-4. PubMed ID: 14991243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG retention index and biologic prognostic parameters in breast cancer.
    García Vicente AM; Castrejón ÁS; Relea Calatayud F; Muñoz AP; León Martín AA; López-Muñiz IC; Del Mar Muñoz Sánchez M; Cordero García JM; Becerra Nakayo EM
    Clin Nucl Med; 2012 May; 37(5):460-6. PubMed ID: 22475895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
    Karan B; Pourbagher A; Torun N
    J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring [(18)F]FDG uptake in breast cancer during chemotherapy: comparison of analytical methods.
    Krak NC; van der Hoeven JJ; Hoekstra OS; Twisk JW; van der Wall E; Lammertsma AA
    Eur J Nucl Med Mol Imaging; 2003 May; 30(5):674-81. PubMed ID: 12640556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
    Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
    Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET of locally invasive breast cancer and association of estrogen receptor status with standardized uptake value: microarray and immunohistochemical analysis.
    Osborne JR; Port E; Gonen M; Doane A; Yeung H; Gerald W; Cook JB; Larson S
    J Nucl Med; 2010 Apr; 51(4):543-50. PubMed ID: 20237034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.